MeSH term
Frequency | Condition_Probility | Humans | 42 | 0.0 |
Animals | 24 | 0.0 |
Apoptosis/drug effects/*physiology | 2 | 0.0 |
Cells, Cultured | 11 | 0.0 |
Rats | 10 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Phosphorylation | 11 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Blotting, Western | 8 | 0.0 |
Gene Expression | 7 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 21 | 3.0 |
Oncogene Proteins/*metabolism | 6 | 7.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 7 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 5 | 0.0 |
Aged | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Female | 8 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
Middle Aged | 4 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Male | 10 | 0.0 |
Mice | 14 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Proteins/genetics | 2 | 0.0 |
*Proto-Oncogene Proteins | 5 | 0.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
Culture Media, Serum-Free/pharmacology | 3 | 2.0 |
Endothelium, Vascular/*cytology/metabolism | 2 | 3.0 |
Gene Expression/physiology | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Cell Line | 3 | 0.0 |
Cell Survival/drug effects | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Oncogene Proteins/genetics/*metabolism | 2 | 4.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 3 | 2.0 |
Neural Cell Adhesion Molecules/*metabolism | 2 | 10.0 |
Proteins/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Oncogene Proteins/genetics/metabolism | 2 | 6.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
Vitamin K/metabolism | 3 | 17.0 |
Base Sequence | 5 | 0.0 |
Oncogene Proteins/*genetics | 5 | 3.0 |
Phenotype | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 5 | 1.0 |
Adenoma/*enzymology/pathology | 2 | 40.0 |
Carcinoma/*enzymology/pathology | 2 | 33.0 |
Disease Progression | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 5 | 2.0 |
In Situ Hybridization | 4 | 0.0 |
Oncogene Proteins/*biosynthesis | 2 | 11.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Proteins/physiology | 2 | 1.0 |
Ligands | 4 | 0.0 |
Oncogene Proteins/genetics | 2 | 2.0 |
Interferon-alpha/pharmacology | 2 | 2.0 |
Kinetics | 4 | 0.0 |
Angiotensin II/pharmacology | 2 | 2.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Receptors, Platelet-Derived Growth Factor/genetics | 2 | 13.0 |
Transcription, Genetic | 2 | 0.0 |
Oncogene Proteins/*physiology | 2 | 8.0 |
Proteins/*physiology | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/*physiology | 2 | 3.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Receptor Protein-Tyrosine Kinases/analysis/*genetics | 2 | 28.0 |
Cell Division | 3 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Oncogene Proteins/metabolism | 6 | 7.0 |
Receptor, Epidermal Growth Factor/metabolism | 2 | 0.0 |
CHO Cells | 4 | 0.0 |
Hamsters | 4 | 0.0 |
Cattle | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Enzyme Activation | 5 | 0.0 |
Protein Binding | 4 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Culture Media, Serum-Free | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transfection | 3 | 0.0 |
Child | 2 | 0.0 |
Intercellular Signaling Peptides and Proteins/*metabolism | 2 | 2.0 |
Kidney/metabolism | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
